164 related articles for article (PubMed ID: 19148534)
1. Anticancer effects on TACC3 by treatment of paclitaxel in HPV-18 positive cervical carcinoma cells.
Yim EK; Tong SY; Ho EM; Bae JH; Um SJ; Park JS
Oncol Rep; 2009 Feb; 21(2):549-57. PubMed ID: 19148534
[TBL] [Abstract][Full Text] [Related]
2. TACC3 depletion sensitizes to paclitaxel-induced cell death and overrides p21WAF-mediated cell cycle arrest.
Schneider L; Essmann F; Kletke A; Rio P; Hanenberg H; Schulze-Osthoff K; Nürnberg B; Piekorz RP
Oncogene; 2008 Jan; 27(1):116-25. PubMed ID: 17599038
[TBL] [Abstract][Full Text] [Related]
3. Prodigiosin down-regulates survivin to facilitate paclitaxel sensitization in human breast carcinoma cell lines.
Ho TF; Peng YT; Chuang SM; Lin SC; Feng BL; Lu CH; Yu WJ; Chang JS; Chang CC
Toxicol Appl Pharmacol; 2009 Mar; 235(2):253-60. PubMed ID: 19133282
[TBL] [Abstract][Full Text] [Related]
4. The centrosomal protein TACC3 controls paclitaxel sensitivity by modulating a premature senescence program.
Schmidt S; Schneider L; Essmann F; Cirstea IC; Kuck F; Kletke A; Jänicke RU; Wiek C; Hanenberg H; Ahmadian MR; Schulze-Osthoff K; Nürnberg B; Piekorz RP
Oncogene; 2010 Nov; 29(46):6184-92. PubMed ID: 20729911
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the mammalian target of rapamycin (mTOR) by rapamycin increases chemosensitivity of CaSki cells to paclitaxel.
Faried LS; Faried A; Kanuma T; Nakazato T; Tamura T; Kuwano H; Minegishi T
Eur J Cancer; 2006 May; 42(7):934-47. PubMed ID: 16540312
[TBL] [Abstract][Full Text] [Related]
6. Differential gene expression profiles in paclitaxel-induced cell cycle arrest and apoptosis in human breast cancer MCF-7 cells.
Wang J; He FT; Tzang CH; Fong WF; Xiao PG; Han R; Yang MS
Yao Xue Xue Bao; 2005 Dec; 40(12):1099-104. PubMed ID: 16496673
[TBL] [Abstract][Full Text] [Related]
7. Effects of paclitaxel on proliferation and apoptosis in human acute myeloid leukemia HL-60 cells.
Wan YF; Guo XQ; Wang ZH; Ying K; Yao MH
Acta Pharmacol Sin; 2004 Mar; 25(3):378-84. PubMed ID: 15000894
[TBL] [Abstract][Full Text] [Related]
8. Differential sensitivity of paclitaxel-induced apoptosis in human esophageal squamous cell carcinoma cell lines.
Faried A; Faried LS; Kimura H; Sohda M; Nakajima M; Miyazaki T; Kato H; Kanuma T; Kuwano H
Cancer Chemother Pharmacol; 2006 Feb; 57(3):301-8. PubMed ID: 16028102
[TBL] [Abstract][Full Text] [Related]
9. miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression.
Li J; Chen Y; Zhao J; Kong F; Zhang Y
Cancer Lett; 2011 May; 304(1):52-9. PubMed ID: 21354697
[TBL] [Abstract][Full Text] [Related]
10. The establishment of two paclitaxel-resistant prostate cancer cell lines and the mechanisms of paclitaxel resistance with two cell lines.
Takeda M; Mizokami A; Mamiya K; Li YQ; Zhang J; Keller ET; Namiki M
Prostate; 2007 Jun; 67(9):955-67. PubMed ID: 17440963
[TBL] [Abstract][Full Text] [Related]
11. Clusterin confers paclitaxel resistance in cervical cancer.
Park DC; Yeo SG; Shin EY; Mok SC; Kim DH
Gynecol Oncol; 2006 Dec; 103(3):996-1000. PubMed ID: 16890274
[TBL] [Abstract][Full Text] [Related]
12. Description of paclitaxel resistance-associated genes in ovarian and breast cancer cell lines.
Duan Z; Lamendola DE; Duan Y; Yusuf RZ; Seiden MV
Cancer Chemother Pharmacol; 2005 Mar; 55(3):277-85. PubMed ID: 15565326
[TBL] [Abstract][Full Text] [Related]
13. Apoptotic mechanism of paclitaxel-induced cell death in human head and neck tumor cell lines.
Hsiao JR; Leu SF; Huang BM
J Oral Pathol Med; 2009 Feb; 38(2):188-97. PubMed ID: 19200178
[TBL] [Abstract][Full Text] [Related]
14. Staurosporine-induced apoptosis of HPV positive and negative human cervical cancer cells from different points in the cell cycle.
Bernard B; Fest T; Prétet JL; Mougin C
Cell Death Differ; 2001 Mar; 8(3):234-44. PubMed ID: 11319606
[TBL] [Abstract][Full Text] [Related]
15. The effect of p53 gene expression on the inhibition of cell proliferation by paclitaxel.
Sakashita F; Osada S; Takemura M; Imai H; Tomita H; Nonaka K; Takahashi T; Seishima M
Cancer Chemother Pharmacol; 2008 Aug; 62(3):379-85. PubMed ID: 17960385
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of MEK sensitizes paclitaxel-induced apoptosis of human colorectal cancer cells by downregulation of GRP78.
Mhaidat NM; Alali FQ; Matalqah SM; Matalka II; Jaradat SA; Al-Sawalha NA; Thorne RF
Anticancer Drugs; 2009 Aug; 20(7):601-6. PubMed ID: 19521235
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of pregnane X receptor contributes to cell growth inhibition and apoptosis by anticancer agents in endometrial cancer cells.
Masuyama H; Nakatsukasa H; Takamoto N; Hiramatsu Y
Mol Pharmacol; 2007 Oct; 72(4):1045-53. PubMed ID: 17636047
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiling of paired ovarian tumors obtained prior to and following adjuvant chemotherapy: molecular signatures of chemoresistant tumors.
L'Espérance S; Popa I; Bachvarova M; Plante M; Patten N; Wu L; Têtu B; Bachvarov D
Int J Oncol; 2006 Jul; 29(1):5-24. PubMed ID: 16773180
[TBL] [Abstract][Full Text] [Related]
19. Stable gene silencing of cyclin B1 in tumor cells increases susceptibility to taxol and leads to growth arrest in vivo.
Yuan J; Krämer A; Matthess Y; Yan R; Spänkuch B; Gätje R; Knecht R; Kaufmann M; Strebhardt K
Oncogene; 2006 Mar; 25(12):1753-62. PubMed ID: 16278675
[TBL] [Abstract][Full Text] [Related]
20. N-acetyltransferase activity is involved in paclitaxel-induced N-acetylation of 2-aminofluorene in human bladder cancer cells (T24).
Yang CC; Yang JH; Lu HF; Chen SY; Lin SY; Chung JG
Anticancer Res; 2004; 24(3a):1501-6. PubMed ID: 15274316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
